UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Risk of secondary progressive multiple sclerosis after early worsening of disability

Journal of neurology, neurosurgery and psychiatry, 2023-12, Vol.94 (12), p.984

2023

Volltextzugriff (PDF)

Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis

Multiple sclerosis, 2018-10, Vol.24 (12), p.1569-1577

2018

Volltextzugriff (PDF)

Fingolimod after natalizumab and the risk of short-term relapse

Neurology, 2014-04, Vol.82 (14), p.1204

2014

Volltextzugriff (PDF)

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (5), p.755-766

2021

Volltextzugriff (PDF)

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

PloS one, 2015-06, Vol.10 (6), p.e0122686-e0122686

2015

Volltextzugriff (PDF)

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Multiple sclerosis, 2024-08, p.13524585241267211

2024

Volltextzugriff (PDF)

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Brain (London, England : 1878), 2013-12, Vol.136 (Pt 12), p.3609-3617

2013

Volltextzugriff (PDF)

Determinants of therapeutic lag in multiple sclerosis

Multiple sclerosis, 2021-10, Vol.27 (12), p.1838-1851

2021

Volltextzugriff (PDF)

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry

Neurodegenerative disease management, 2023-08, Vol.13 (4), p.215-221

2023

Volltextzugriff (PDF)

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

PloS one, 2013-05, Vol.8 (5), p.e63480

2013

Volltextzugriff (PDF)

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.1343-1349

2016

Volltextzugriff (PDF)

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A2-A2

2021

Volltextzugriff (PDF)

The personality profile and alexithymic syndrome in primary headache: a Rorschach study

Journal of headache and pain, 2001-06, Vol.2 (1), p.31-37

2001

Volltextzugriff (PDF)

Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate

Metabolism, clinical and experimental, 2015-09, Vol.64 (9), p.1112-1121

2015

Volltextzugriff (PDF)

The role of 13 C excited states in α + 9 Be reaction and scattering cross sections

EPJ Web of conferences, 2017, Vol.165, p.1036

2017

Volltextzugriff (PDF)

Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features

Clinical genitourinary cancer, 2015-02, Vol.13 (1), p.e31-e35

2015

Volltextzugriff (PDF)

Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?

International urology and nephrology, 2014-06, Vol.46 (6), p.1131-1135

2014

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)
Tagungsberichte
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(14)
Multiple Sclerosis
(13)
Humans
(12)
Clinical Neurology
(11)
Neurosciences & Neurology
(11)
Adult
(10)
Male
(10)
Female
(8)
Neurosciences
(8)
Middle Aged
(7)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(6)
Multiple Sclerosis - Drug Therapy
(5)
Aged
(4)
Neurology
(4)
Patients
(4)
Recurrence
(4)
Disease Progression
(3)
Immunosuppressive Agents - Therapeutic Use
(3)
Registries
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

Risk of secondary progressive multiple sclerosis after early worsening of disability

Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis

Fingolimod after natalizumab and the risk of short-term relapse

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Determinants of therapeutic lag in multiple sclerosis

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

The personality profile and alexithymic syndrome in primary headache: a Rorschach study

Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate

The role of 13 C excited states in α + 9 Be reaction and scattering cross sections

Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features

The 10 B(p, α ) 7 Be S(E)-factor from 5 keV to 1.5 MeV using the Trojan Horse Method

Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?

The 10B(p,α)7Be S(E)-factor from 5 keV to 1.5 MeV using the Trojan Horse Method

Suchergebnisse filtern